AMRS - Amyris, Inc.
3.0800 0.00 (0.00%)
After hours: 4:10PM EDT
| Previous Close | 3.1200 |
| Open | 3.1100 |
| Bid | 3.0700 x 3100 |
| Ask | 3.0800 x 1800 |
| Day's Range | 3.0400 - 3.1900 |
| 52 Week Range | 1.8700 - 9.2900 |
| Volume | 276,339 |
| Avg. Volume | 1,284,883 |
| Market Cap | 317.098M |
| Beta (3Y Monthly) | 1.60 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.5220 |
| Earnings Date | Jul 16, 2019 - Jul 19, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.00 |
- PR Newswire•4 days ago
Amyris to Participate in and Provide Business Update at Jefferies 2019 Global Industrials Conference
EMERYVILLE, Calif., July 12, 2019 /PRNewswire/ -- Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that it plans to participate in the following upcoming investor conference in August 2019. Amyris will provide an update on its business during the presentation. A live webcast of the presentation including slides and a replay will be available on the investor relations section of the company's website at http://investors.amyris.com. Amyris is the integrated renewable products company that is enabling the world's leading brands to achieve sustainable growth.
- GlobeNewswire•18 days ago
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Inogen, Health Insurance Innovations, Amyris and Nutanix and Encourages Investors to Contact the Firm
Bragar Eagel & Squire is investigating certain officers and directors of Inogen, Inc., Health Insurance Innovations, Inc., Amyris, Inc., and Nutanix, Inc. More information about each potential case can be found at the link provided. Bragar Eagel and Squire is investigating certain officers and directors of Inogen following a class action complaint that was filed against Inogen on March 6, 2019.
- PR Newswire•19 days ago
Jonathan Van Ness Joins BIOSSANCE as First Celebrity Ambassador
EMERYVILLE, Calif., June 27, 2019 /PRNewswire/ -- Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that television personality, podcaster, comedian and beauty expert to the stars Jonathan Van Ness has joined Biossance as the first celebrity ambassador for the brand. The partnership with Jonathan Van Ness marks a milestone in visibility for the brand to advance its mission to make clean the new standard in beauty. "I love incorporating skincare that helps me feel and look my best, while also coming from ethical and sustainably sourced places," says Jonathan Van Ness. "Since the start of my career in the beauty industry, I have been inspired by companies that blend nature and science to create skincare that helps improve the health of skin and people's knowledge of what the ingredients really do.
- PR Newswire•last month
Berkeley Lights, Inc. And Amyris Announce Collaboration To Speed Testing Of Microbial Strains
This is the first application of BLI's Beacon® platform for microbial strains within synthetic biology. The goal of the collaboration is to implement the Beacon platform to identify and isolate microbial strains that produce the highest quantities of non-therapeutic product.
- PR Newswire•last month
Amyris Appoints Kathleen Valiasek Chief Business Officer-Appoints Jonathan Wolter as Interim CFO
EMERYVILLE, Calif., June 4, 2019 /PRNewswire/ -- Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced the appointment of Kathleen Valiasek, formerly Chief Financial Officer, to Chief Business Officer effective immediately. Valiasek will assume a dedicated role of furthering the company's strategy of collaborating with large, well-funded partners to grow the company's business. Simultaneously, she will continue to oversee the company's financing and investor relations activities.
- GlobeNewswire•last month
AMRS & CRCM - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Deadline
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq.
- GlobeNewswire•last month
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Amyris, Inc. (“Amyris” or “the Company”) (NASDAQ: AMRS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.
- ACCESSWIRE•last month
AMRS & CRCM -Deadline Alert - Bronstein, Gewirtz & Grossman, LLC
NEW YORK, NY / ACCESSWIRE / June 3, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review ...
- GlobeNewswire•last month
AMYRIS 24 HOUR DEADLINE ALERT: APPROXIMATELY 24 HOURS REMAIN; FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Action Lawsuit Against Amyris, Inc. - AMRS
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until June 3, 2019 to file lead plaintiff applications in a securities class action lawsuit against Amyris, Inc. (AMRS). Investor losses must relate to purchases of the Company’s securities between March 15, 2018 and March 19, 2019. This action is pending in the United States District Court for the Northern District of California.
- ACCESSWIRE•last month
FINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Amyris, Inc. and Encourages Investors with Losses in Excess of $50,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / June 2, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Amyris, Inc. ("Amyris" or "the Company") (NASDAQ: AMRS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between March 15, 2018 and March 19, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before June 3, 2019.
- Motley Fool•last month
Will Amyris Wisely Return Its Focus to Consumer Brands?
An overlooked announcement provides an opportunity for a management team that has lost the trust of investors.
- Business Wire•last month
AMYRIS 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit against Amyris, Inc. - AMRS
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until June 3, 2019 to file lead plaintiff applications in a securities class action lawsuit against Amyris, Inc. (AMRS). Investor losses must relate to purchases of the Company’s securities between March 15, 2018 and March 19, 2019.
- GlobeNewswire•2 months ago
Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amyris, Inc.
Law Offices of Howard G. Smith reminds investors of the upcoming June 3, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Amyris, Inc. (“Amyris” or the “Company”) (NASDAQ: AMRS) securities between March 15, 2018 and March 19, 2019, inclusive (the “Class Period”). Investors suffering losses on their Amyris investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.
- ACCESSWIRE•2 months ago
IMPORTANT JUNE 3 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 31, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Amyris, Inc. ("Amyris" or "the Company") (NASDAQ: AMRS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between March 15, 2018 and March 19, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before June 3, 2019.
- GlobeNewswire•2 months ago
KESSLER TOPAZ MELTZER & CHECK, LLP: Final Deadline Reminder for AMYRIS, INC. Investors – AMRS
The law firm of Kessler Topaz Meltzer & Check, LLP reminds Amyris, Inc. (Nasdaq: AMRS) (“Amyris”) investors that a securities fraud class action lawsuit has been filed on behalf of those who purchased or otherwise acquired Amyris securities between March 15, 2018 and March 19, 2019, inclusive (the “Class Period”). REMINDER: Investors who purchased Amyris securities during the Class Period may, no later than June 3, 2019, seek to be appointed as a lead plaintiff representative of the class.
- ACCESSWIRE•2 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amyris, Inc. - AMRS
NEW YORK, NY / ACCESSWIRE / May 30, 2019 / Pomerantz LLP is investigating claims on behalf of investors of Amyris, Inc. ("Amyris" or the "Company") (AMRS). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. The investigation concerns whether Amyris and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
- GlobeNewswire•2 months ago
AMYRIS MONDAY DEADLINE: Rosen, a Top Ranked Law Firm, Reminds Investors of Amyris, Inc. of Important June 3rd Deadline in Securities Class Action – AMRS
NEW YORK, May 30, 2019 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Amyris, Inc. (NASDAQ: AMRS) from March 15, 2018 and March.
- ACCESSWIRE•2 months ago
4-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 30, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Amyris, Inc. ("Amyris" or "the Company") (NASDAQ: AMRS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between March 15, 2018 and March 19, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before June 3, 2019.
- GlobeNewswire•2 months ago
T, AMRS & CRCM - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Deadline
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq.
- GlobeNewswire•2 months ago
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Amyris, Flex, comScore, and Mueller Water and Encourages Investors to Contact the Firm
NEW YORK, May 29, 2019 -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Amyris, Inc., Flex Ltd.,.
- ACCESSWIRE•2 months ago
6-DAY DEALINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Amyris, Inc.
RADNOR, PA / ACCESSWIRE / May 29, 2019 / The law firm of Kessler Topaz Meltzer & Check, LLP reminds Amyris, Inc. (AMRS) ("Amyris") investors that a securities fraud class action lawsuit has been filed on behalf of those who purchased or otherwise acquired Amyris securities between March 15, 2018 and March 19, 2019, inclusive (the "Class Period"). REMINDER: Investors who purchased Amyris securities during the Class Period may, no later than June 3, 2019, seek to be appointed as a lead plaintiff representative of the class.
- ACCESSWIRE•2 months ago
FINAL DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 29, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Amyris, Inc. ("Amyris" or "the Company") (NASDAQ: AMRS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between March 15, 2018 and March 19, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before June 3, 2019.
- GlobeNewswire•2 months ago
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amyris, Inc.
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming June 3, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of Amyris, Inc. (“Amyris” or the “Company”) (NASDAQ: AMRS) investors who purchased securities between March 15, 2018, and March 19, 2019, inclusive (the “Class Period”). If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at 310-201-9150, Toll-Free at 888-773-9224, or by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com.
- Business Wire•2 months ago
INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Amyris, Inc.
The law firm of Kessler Topaz Meltzer & Check, LLP reminds Amyris, Inc. (AMRS) (“Amyris”) investors that a securities fraud class action lawsuit has been filed on behalf of those who purchased or otherwise acquired Amyris securities between March 15, 2018 and March 19, 2019, inclusive (the “Class Period”). REMINDER: Investors who purchased Amyris securities during the Class Period may, no later than June 3, 2019, seek to be appointed as a lead plaintiff representative of the class.
